A reduction in circulating prolactin levels was observed in a subgroup of patients in whom hyperprolactinaemia was unrelated to prolactinoma and, therefore, could not be associated with a decrease in tumour size and/or tumour apoplexy. This evidence concerns the gene PRL and Increased circulating prolactin concentration.